Related articles from FindarticlesJournal of Family Practice - Does long-term use of sibutramine result in continued weight loss in short-term responders? - Meridia - POEMs
December 1, 2001 -- Wirth A, Krause J. Long-term weight loss with sibutramine: a randomized controlled trial. JAMA 2001; 286:1331-39. * BACKGROUND Obesity, defined as...Journal of Family Practice - Randomized Placebo-Controlled Trial of Long-Term Treatment with Sibutramine in Mild to Moderate Obesity
June 1, 2001 -- * OBJECTIVE We assessed the long-term weight reduction efficacy, tolerability, and safety of sibutramine used once daily in conjunction with behavior...Nutrition Research Newsletter - Effects Of Sibutramine Plus Orlistat In Obese Women
October 1, 2000 -- Two medications, sibutramine (Meridia; Knoll Pharmaceutical Co., Mt. Olive, NJ) and orlistat (Xenical; Roche Laboratories, Nutley, NJ), are currently...Nutrition Research Newsletter - How Obesity Drugs Affect The Autonomic Nervous System - Brief Article - Statistical Data Included
July 1, 2000 -- It is believed that a variety of afferent stimuli are detected by a central mechanism that changes body fat level by adjusting food intake and...Nutrition Research Newsletter - Six-Month Trial Of Sibutramine For Obesity Treatment - Brief Article - Statistical Data Included
May 1, 2000 -- Sibutramine (Meridia), a new drug approved for the long-term treatment of obesity, is a serotonin and noradrenaline reuptake inhibitor, which...Business Wire - Knoll Pharmaceutical Company Begins Nationwide Distribution of New Anti-Obesity Agent, MERIDIA
February 12, 1998 -- MT. OLIVE, N.J.--(BUSINESS WIRE)--Feb. 12, 1998-- Educational Campaigns for Physicians, Patients, Knoll Employees Support... |
|
